Johnson Matthey Plc (JMAT):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Johnson Matthey Plc (JMAT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9983
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Johnson Matthey Plc (Johnson Matthey) is a specialty chemicals and sustainable technologies provider. It offers catalysts, fine chemicals, specialty chemical products and related technologies for various chemical processes and applications. It also undertakes the marketing, distribution, fabrication, refining and recycling of precious metals and their products. It also develops and manufactures active pharmaceutical ingredients (APIs) for a variety of treatments. The company provides battery materials for automotive applications, battery systems for a range of applications and fuel cell technologies. Johnson Matthey serves environmental, automotive, chemical, medical, recycling, oil and gas and other industries. The company operates in the UK, Germany, the US, Mexico, Belgium, Russia, Japan, Malaysia, India, South Africa, China, Argentina, and South Korea. Johnson Matthey is headquartered in London, the UK.

Johnson Matthey Plc (JMAT) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Johnson Matthey Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Intrexon and Johnson Matthey Enter into Agreement 10
Johnson Matthey and Domainex Enter into Partnership 11
Asset Transactions 12
Endo Pharma Acquires US Patents For Oxymorphone From Johnson Matthey 12
Acquisition 13
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 13
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 14
Johnson Matthey Plc – Key Competitors 15
Johnson Matthey Plc – Key Employees 16
Johnson Matthey Plc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Johnson Matthey Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Johnson Matthey Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Intrexon and Johnson Matthey Enter into Agreement 10
Johnson Matthey and Domainex Enter into Partnership 11
Endo Pharma Acquires US Patents For Oxymorphone From Johnson Matthey 12
Johnson Matthey Acquires SAFC Pharmorphix from Sigma-Aldrich 13
Thermo Fisher Scientific Acquires Alfa Aesar for USD403 Million 14
Johnson Matthey Plc, Key Competitors 15
Johnson Matthey Plc, Key Employees 16
Johnson Matthey Plc, Other Locations 17
Johnson Matthey Plc, Subsidiaries 17
Johnson Matthey Plc, Joint Venture 19

List of Figures
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Johnson Matthey Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Johnson Matthey Plc (JMAT):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Western Farmers Electric Cooperative:発電所・企業SWOT分析
    Western Farmers Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Crew Energy Inc (CR):企業の財務・戦略的SWOT分析
    Summary Crew Energy Inc (Crew Energy) is an exploration and production company that offers our long-term production and development of crude oil and natural gas resources. The company offers exploration, development, strategic acquisitions, operations, management, and production programs. It operate …
  • Nissin Foods Holdings Co. Ltd:企業の戦略・SWOT・財務情報
    Nissin Foods Holdings Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary Nissin Foods Holdings Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nikon Corporation:企業の戦略・SWOT・財務分析
    Nikon Corporation - Strategy, SWOT and Corporate Finance Report Summary Nikon Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Thin Film Electronics ASA (THIN):企業の財務・戦略的SWOT分析
    Thin Film Electronics ASA (THIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • NCsoft Corporation (036570):企業の財務・戦略的SWOT分析
    NCsoft Corporation (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Lombard Odier Private Clients:企業の戦略・SWOT・財務情報
    Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report Summary Lombard Odier Private Clients - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Medicines for Malaria Venture-製薬・医療分野:企業M&A・提携分析
    Summary Medicines for Malaria Venture (MMV) is a drug development and manufacturing company that discovers, develops and delivers anti malarial drugs. The company offers products that provide efficacy against drug-resistant strains of plasmodium falciparum, potential for intermittent treatments, saf …
  • Hexza Corp Bhd (HEXZA):企業の財務・戦略的SWOT分析
    Hexza Corp Bhd (HEXZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Finisar Corp (FNSR):企業の財務・戦略的SWOT分析
    Summary Finisar Corp (Finisar), a subsidiary of II-VI Inc, is a technology company that offers optical communication products. The company offers products such as optical transceivers, optical cables, optical engines, optical components, optical instrumentation, ROADMs, and optical amplifiers. It of …
  • PolyOne Corp (POL):企業の財務・戦略的SWOT分析
    PolyOne Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Auven Therapeutics Management LLLP-製薬・医療分野:企業M&A・提携分析
    Summary Auven Therapeutics Management LLLP (Auven Therapeutics Management), formerly Celtic Therapeutics Management LLLP is a private equity firm that provides life science investment strategy. The firm invests in therapeutic products or platforms. It has invested in diversified portfolio of biologi …
  • Merck & Co., Inc.:企業の戦略・SWOT・財務情報
    Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report Summary Merck & Co., Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Best Buy Co, Inc.:企業のM&A・事業提携・投資動向
    Best Buy Co, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Best Buy Co, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • German Cancer Research Center-医療機器分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • Dr. Langer Medical GmbH:企業の戦略的SWOT分析
    Dr. Langer Medical GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Haisco Pharmaceutical Group Co Ltd (002653)-医療機器分野:企業M&A・提携分析
    Summary Haisco Pharmaceutical Group Co Ltd (Haisco Pharma), formerly Xizang Haisco Pharmaceutical Group Co Ltd is a developer and marketer of chemical drug preparations and bulk drugs. The company's product portfolio comprises injection for trace elements, compound vitamin, invert sugar, fat soluble …
  • BerGenBio ASA (BGBIO):製薬・医療:M&Aディール及び事業提携情報
    Summary BerGenBio ASA (BerGenBio) is a clinical-stage biopharmaceutical company that develops drugs to treat multiple aggressive cancers. The company develops epithelial-mesenchymal transition inhibitors for acquired cancer drug-resistance and metastasis. Its BGB324 is an AXL kinase inhibitor which …
  • Clinical Laserthermia Systems AB (CLS B):企業の製品パイプライン分析2018
    Summary Clinical Laserthermia Systems AB (CLS) develops and markets systems and single-use instruments for the treatment of solid cancer tumors. The company's flagship product TRANBERG, a cancer immunotherapy system consists of a mobile laser unit and single-use products developed to perform a preci …
  • CardioComm Solutions Inc (EKG):企業の製品パイプライン分析
    Summary CardioComm Solutions Inc (CardioComm) is a medical technology company that offers software solutions for information management systems in cardiovascular medicine and telemedicine. It offers software engineering of computer based electrocardiogram management and reporting software. Its produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆